Mixture survival models methodology: an application to cancer immunotherapy assessment in clinical trials. (arXiv:1911.09765v1 [stat.AP]) http://arxiv.org/abs/1911.09765
CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.